Safety, efficacy, and PK/PD of vorasidenib in previously treated patients with mIDH1/2 hematologic malignancies: A phase 1 study.

Authors	Courtney D DiNardo, Stéphane De Botton, Daniel A Pollyea, Richard M Stone, Jessica K Altman, Amir T Fathi, Tharin Limsakun, Min Liang, Sung Choe, Mohammad Hossain, Adriana E Tron, Qian Meng, Stephanie M Kapsalis, Shuchi S Pandya, Eytan M Stein
Journal	American journal of hematology (Am J Hematol) Vol. 98 Issue 9 Pg. E233-E236 (09 2023) ISSN: 1096-8652 [Electronic] United States
PMID	37354069 (Publication Type: Clinical Trial, Phase I, Research Support, Non-U.S. Gov't, Journal Article)
Chemical References	vorasidenib Pyridines Diamines
Topics	Humans Hematologic Neoplasms (drug therapy) Pyridines (adverse effects) Diamines

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!